Global C-reactive Protein Market By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), Detection Range (hs-CRP, Conventional CRP, cCRP), Disease (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Infla mmatory Bowel Disease, Endometriosis, Lupus, Syphilis, Inflammatory Diseases, Diabetes, Others), Analysis Mode (Serum, Plasma, Blood), End- User (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others), Product Type (Kits, Reagents)
Market Analysis: Global C-reactive Protein Market
Global C – reactive protein market is expected to rise to an estimated value of USD 1.99 billion by 2026, registering a steady CAGR in the forecast period of 2019-2026. Increasing cardiovascular diseases among population and increasing ageing population is driving the growth of this market.
Enquiry About Report @
Global C–reactive protein market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of C–reactive protein market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Segmentation: Global C-reactive Protein Market
By Assay Type
- Immunoturbidimetric Assay
- Chemiluminescence Immunoassay
By Detection Range
- Conventional CRP
- Cardiovascular Diseases
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Inflammatory Diseases
By Analysis Mode
By End- User
- Assisted Living Healthcare Facilities
By Product Type
Get Detailed Speak to Analyst @
Market Definition: Global C-reactive Protein Market
Global C – reactive protein market is a protein which is found in the liver whose concentration usually increases due to rise in the inflammation. To detect the inflammation in infection, cancer, autoimmune disorders and other diseases, C- reactive protein test are used. These tests are also used to detect the heart attack C-reactive protein test cannot identify the direct cause of inflammation, but indicates inflammation level triggered by other causes. Increasing cases of diabetes worldwide is the major factor fueling the market growth.
- Increasing R&D in C- reactive protein is driving the growth of this market
- Rising inflammatory disease cases among population is another factor driving the market growth
- Rising geriatric population worldwide is driving the market growth
- Availability of alternatives in the market is restraining the market growth
- Lack of skilled and trained professional is another factor restraining the market growth
Key Developments in the Market:
In October 2018, RPS Diagnostics, Inc announced the launch that they have received CE mark of its FebriDx test. With the help of the fingerstick blood sample it will help the doctors to analyze the body’s immune response to an acute respiratory infection within 10 minutes. This device is specially designed to identify different infections and ARI
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research